Cargando…
Importance of Treatment Duration: Unmasking Barriers and Discovering the Reasons for Undertreatment of Anti-VEGF Agents in Neovascular Age-Related Macular Degeneration
PURPOSE: Since non-adherence (NA) to intravitreal therapy with VEGF drugs is one of the most important modifiable factors compromising treatment outcome of nAMD, the purpose of this study was to investigate the contributing factors and barriers during long-term nAMD treatment. METHODS: Barriers and...
Autores principales: | Sobolewska, Bianka, Sabsabi, Muhammed, Ziemssen, Focke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558036/ https://www.ncbi.nlm.nih.gov/pubmed/34737546 http://dx.doi.org/10.2147/OPTH.S325763 |
Ejemplares similares
-
pH of anti-VEGF agents in the human vitreous: low impact of very different formulations
por: Sobolewska, Bianka, et al.
Publicado: (2017) -
Correction to: pH of anti-VEGF agents in the human vitreous: low impact of very different formulations
por: Sobolewska, Bianka, et al.
Publicado: (2017) -
Multitask Learning for Activity Detection in Neovascular Age-Related Macular Degeneration
por: Ayhan, Murat Seçkin, et al.
Publicado: (2023) -
Reasons for Delayed Anti-VEGF Treatment During COVID-19 Lockdown and Clinical Impact in Neovascular Age-Related Macular Degeneration
por: Zarranz-Ventura, Javier, et al.
Publicado: (2023) -
Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
por: Kaiser, Stephanie M, et al.
Publicado: (2021)